Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good reason.

Neurocrine Biosciences Inc (NASDAQ:NBIX) Scores High in Affordable Growth Screen

The "Affordable Growth" strategy targets stocks with strong growth and reasonable valuations. Neurocrine Biosciences (NBIX) fits perfectly,

India’s lifesciences sector sees momentum build in innovation: BCG -HealthKois report

Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March 2026, and biotech

Quest Diagnostics (NYSE:DGX) Offers a Secure and Sustainable Dividend with Strong Profitability

Quest Diagnostics (DGX) passes the "Best Dividend" screen with a sustainable 1.59% yield, low 35% payout ratio, and strong profitability. A

AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years

A Look at Biogen Inc (BIIB) After 5.0% Gain -- GF Value $191.79 vs Price $209.03

Related Stocks: BIIB